Effects of low-dose aspirin on endogenous eicosanoid formation in normal and atherosclerotic men
- 1 May 1988
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 50 (3), 377-386
- https://doi.org/10.1016/0049-3848(88)90267-8
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- In Vivo Indexes of Platelet and Vascular Function during Fish-Oil Administration in Patients with AtherosclerosisNew England Journal of Medicine, 1986
- The human pharmacology of platelet inhibition: pharmacokinetics relevant to drug action.Circulation, 1985
- Selective inhibition of thromboxane-related platelet function by low-dose aspirin in patients after myocardial infarctionThe American Journal of Cardiology, 1985
- Cumulative inhibitory effect of low-dose aspirin on vascular prostacyclin and platelet thromboxane production in patients with atherosclerosis.Circulation, 1985
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.JCI Insight, 1983
- Persantine Aspirin Trial in cerebral ischemia. The American-Canadian Co-operative Study Group.Stroke, 1983
- DIFFERENTIAL INHIBITION BY LOW-DOSE ASPIRIN OF HUMAN VENOUS PROSTACYCLIN SYNTHESIS AND PLATELET THROMBOXANE SYNTHESISThe Lancet, 1981
- DIFFERENTIAL INHIBITION OF PROSTACYCLIN PRODUCTION AND PLATELET AGGREGATION BY ASPIRINThe Lancet, 1979
- Inhibition of platelet prostaglandin synthetase by oral aspirin.JCI Insight, 1978